Muscleblind participates in RNA toxicity of expanded CAG and CUG repeats in Caenorhabditis elegans (original) (raw)

References

  1. Moseley ML, Zu T, Ikeda Y, Gao W, Mosemiller AK, Daughters RS, Chen G, Weatherspoon MR, Clark HB, Ebner TJ, Day JW, Ranum LP (2006) Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8. Nat Genet 38:758–769
    Article PubMed CAS Google Scholar
  2. Holmes SE, O’Hearn EE, McInnis MG, Gorelick-Feldman DA, Kleiderlein JJ, Callahan C, Kwak NG, Ingersoll-Ashworth RG, Sherr M, Sumner AJ, Sharp AH, Ananth U, Seltzer WK, Boss MA, Vieria-Saecker AM, Epplen JT, Riess O, Ross CA, Margolis RL (1999) Expansion of a novel CAG trinucleotide repeat in the 5′ region of PPP2R2B is associated with SCA12. Nat Genet 23:391–392
    Article PubMed CAS Google Scholar
  3. Holmes SE, O’Hearn E, Rosenblatt A, Callahan C, Hwang HS, Ingersoll-Ashworth RG, Fleisher A, Stevanin G, Brice A, Potter NT, Ross CA, Margolis RL (2001) A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease-like 2. Nat Genet 29:377–378
    Article PubMed CAS Google Scholar
  4. Ranum LP, Day JW (2004) Pathogenic RNA repeats: an expanding role in genetic disease. Trends Genet 20:506–512
    Article PubMed CAS Google Scholar
  5. Osborne RJ, Thornton CA (2006) RNA-dominant diseases. Hum Mol Genet 15(Spec No 2):R162–R169
    Article PubMed CAS Google Scholar
  6. Wheeler TM, Thornton CA (2007) Myotonic dystrophy: RNA-mediated muscle disease. Curr Opin Neurol 20:572–576
    Article PubMed CAS Google Scholar
  7. Michlewski G, Krzyzosiak WJ (2005) Pathogenesis of spinocerebellar ataxias viewed from the RNA perspective. Cerebellum 4:19–24
    Article PubMed CAS Google Scholar
  8. Ranum LP, Cooper TA (2006) RNA-mediated neuromuscular disorders. Annu Rev Neurosci 29:259–277
    Article PubMed CAS Google Scholar
  9. Mankodi A, Logigian E, Callahan L, McClain C, White R, Henderson D, Krym M, Thornton CA (2000) Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 289:1769–1773
    Article PubMed CAS Google Scholar
  10. Seznec H, Agbulut O, Sergeant N, Savouret C, Ghestem A, Tabti N, Willer JC, Ourth L, Duros C, Brisson E, Fouquet C, Butler-Browne G, Delacourte A, Junien C, Gourdon G (2001) Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities. Hum Mol Genet 10:2717–2726
    Article PubMed CAS Google Scholar
  11. Timchenko LT, Miller JW, Timchenko NA, DeVore DR, Datar KV, Lin L, Roberts R, Caskey CT, Swanson MS (1996) Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucleic Acids Res 24:4407–4414
    Article PubMed CAS Google Scholar
  12. Miller JW, Urbinati CR, Teng-Umnuay P, Stenberg MG, Byrne BJ, Thornton CA, Swanson MS (2000) Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J 19:4439–4448
    Article PubMed CAS Google Scholar
  13. Philips AV, Timchenko LT, Cooper TA (1998) Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 280:737–741
    Article PubMed CAS Google Scholar
  14. Kanadia RN, Johnstone KA, Mankodi A, Lungu C, Thornton CA, Esson D, Timmers AM, Hauswirth WW, Swanson MS (2003) A muscleblind knockout model for myotonic dystrophy. Science 302:1978–1980
    Article PubMed CAS Google Scholar
  15. Ho TH, Charlet BN, Poulos MG, Singh G, Swanson MS, Cooper TA (2004) Muscleblind proteins regulate alternative splicing. EMBO J 23:3103–3112
    Article PubMed CAS Google Scholar
  16. Timchenko NA, Cai ZJ, Welm AL, Reddy S, Ashizawa T, Timchenko LT (2001) RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1. J Biol Chem 276:7820–7826
    Article PubMed CAS Google Scholar
  17. Kuyumcu-Martinez NM, Wang GS, Cooper TA (2007) Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation. Mol Cell 28:68–78
    Article PubMed CAS Google Scholar
  18. Ho TH, Bundman D, Armstrong DL, Cooper TA (2005) Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy. Hum Mol Genet 14:1539–1547
    Article PubMed CAS Google Scholar
  19. Begemann G, Paricio N, Artero R, Kiss I, Perez-Alonso M, Mlodzik M (1997) Muscleblind, a gene required for photoreceptor differentiation in Drosophila, encodes novel nuclear Cys3His-type zinc-finger-containing proteins. Development 124:4321–4331
    PubMed CAS Google Scholar
  20. Artero R, Prokop A, Paricio N, Begemann G, Pueyo I, Mlodzik M, Perez-Alonso M, Baylies MK (1998) The muscleblind gene participates in the organization of Z-bands and epidermal attachments of Drosophila muscles and is regulated by Dmef2. Dev Biol 195:131–143
    Article PubMed CAS Google Scholar
  21. Fardaei M, Rogers MT, Thorpe HM, Larkin K, Hamshere MG, Harper PS, Brook JD (2002) Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum Mol Genet 11:805–814
    Article PubMed CAS Google Scholar
  22. Squillace RM, Chenault DM, Wang EH (2002) Inhibition of muscle differentiation by the novel muscleblind-related protein CHCR. Dev Biol 250:218–230
    Article PubMed CAS Google Scholar
  23. Adereth Y, Dammai V, Kose N, Li R, Hsu T (2005) RNA-dependent integrin alpha3 protein localization regulated by the Muscleblind-like protein MLP1. Nat Cell Biol 7:1240–1247
    Article PubMed Google Scholar
  24. Lee KS, Smith K, Amieux PS, Wang EH (2008) MBNL3/CHCR prevents myogenic differentiation by inhibiting MyoD-dependent gene transcription. Differentiation 76:299–309
    Article PubMed CAS Google Scholar
  25. Kanadia RN, Shin J, Yuan Y, Beattie SG, Wheeler TM, Thornton CA, Swanson MS (2006) Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy. Proc Natl Acad Sci USA 103:11748–11753
    Article PubMed CAS Google Scholar
  26. Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, Day JW, Ranum LP (2001) Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293:864–867
    Article PubMed CAS Google Scholar
  27. Mankodi A, Urbinati CR, Yuan QP, Moxley RT, Sansone V, Krym M, Henderson D, Schalling M, Swanson MS, Thornton CA (2001) Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum Mol Genet 10:2165–2170
    Article PubMed CAS Google Scholar
  28. Savkur RS, Philips AV, Cooper TA, Dalton JC, Moseley ML, Ranum LP, Day JW (2004) Insulin receptor splicing alteration in myotonic dystrophy type 2. Am J Hum Genet 74:1309–1313
    Article PubMed CAS Google Scholar
  29. Sobczak K, de Mezer M, Michlewski G, Krol J, Krzyzosiak WJ (2003) RNA structure of trinucleotide repeats associated with human neurological diseases. Nucleic Acids Res 31:5469–5482
    Article PubMed CAS Google Scholar
  30. Ho TH, Savkur RS, Poulos MG, Mancini MA, Swanson MS, Cooper TA (2005) Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy. J Cell Sci 118:2923–2933
    Article PubMed CAS Google Scholar
  31. Kino Y, Mori D, Oma Y, Takeshita Y, Sasagawa N, Ishiura S (2004) Muscleblind protein, MBNL1/EXP, binds specifically to CHHG repeats. Hum Mol Genet 13:495–507
    Article PubMed CAS Google Scholar
  32. Yuan Y, Compton SA, Sobczak K, Stenberg MG, Thornton CA, Griffith JD, Swanson MS (2007) Muscleblind-like 1 interacts with RNA hairpins in splicing target and pathogenic RNAs. Nucleic Acids Res 35:5474–5486
    Article PubMed CAS Google Scholar
  33. McLeod CJ, O’Keefe LV, Richards RI (2005) The pathogenic agent in Drosophila models of ‘polyglutamine’ diseases. Hum Mol Genet 14:1041–1048
    Article PubMed CAS Google Scholar
  34. Li LB, Yu Z, Teng X, Bonini NM (2008) RNA toxicity is a component of ataxin-3 degeneration in Drosophila. Nature 453:1107–1111
    Article PubMed CAS Google Scholar
  35. Faber PW, Alter JR, MacDonald ME, Hart AC (1999) Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron. Proc Natl Acad Sci USA 96:179–184
    Article PubMed CAS Google Scholar
  36. Parker JA, Connolly JB, Wellington C, Hayden M, Dausset J, Neri C (2001) Expanded polyglutamines in Caenorhabditis elegans cause axonal abnormalities and severe dysfunction of PLM mechanosensory neurons without cell death. Proc Natl Acad Sci USA 98:13318–13323
    Article PubMed CAS Google Scholar
  37. Morley JF, Brignull HR, Weyers JJ, Morimoto RI (2002) The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans. Proc Natl Acad Sci USA 99:10417–10422
    Article PubMed Google Scholar
  38. Chen KY, Pan H, Lin MJ, Li YY, Wang LC, Wu YC, Hsiao KM (2007) Length-dependent toxicity of untranslated CUG repeats on Caenorhabditis elegans. Biochem Biophys Res Commun 352:774–779
    Article PubMed CAS Google Scholar
  39. Wang LC, Hung WT, Pan H, Chen KY, Wu YC, Liu YF, Hsiao KM (2008) Growth-dependent effect of muscleblind knockdown on Caenorhabditis elegans. Biochem Biophys Res Commun 366:705–709
    Article PubMed CAS Google Scholar
  40. Mello C, Fire A (1995) DNA transformation. Methods Cell Biol 48:451–482
    Article PubMed CAS Google Scholar
  41. Brenner S (1974) The genetics of Caenorhabditis elegans. Genetics 77:71–94
    PubMed CAS Google Scholar
  42. Lewis JA, Fleming JT (1995) Basic culture methods. Methods Cell Biol 48:3–29
    Article PubMed CAS Google Scholar
  43. Waterston RH, Hirsh D, Lane TR (1984) Dominant mutations affecting muscle structure in Caenorhabditis elegans that map near the actin gene cluster. J Mol Biol 180:473–496
    Article PubMed CAS Google Scholar
  44. Hall DH (1995) Electron microscopy and 3D image reconstruction. In: Epstein HF, Shakes DC (eds) C. elegans: modern biological analysis of an organism. Methods in cell biology, vol. 48. Academic Press, New York, 395–436
  45. Nonet ML, Staunton JE, Kilgard MP, Fergestad T, Hartwieg E, Horvitz HR, Jorgensen EM, Meyer BJ (1997) Caenorhabditis elegans rab-3 mutant synapses exhibit impaired function and are partially depleted of vesicles. J Neurosci 17:8061–8073
    PubMed CAS Google Scholar
  46. Albertson DG, Fishpool RM, Birchall PS (1995) Fluorescence in situ hybridization for the detection of DNA and RNA. Methods Cell Biol 48:339–364
    Article PubMed CAS Google Scholar
  47. Fakhari FD, Dittmer DP (2002) Charting latency transcripts in Kaposi’s sarcoma-associated herpesvirus by whole-genome real-time quantitative PCR. J Virol 76:6213–6223
    Article PubMed CAS Google Scholar
  48. Dittmer DP (2003) Transcription profile of Kaposi’s sarcoma-associated herpesvirus in primary Kaposi’s sarcoma lesions as determined by real-time PCR arrays. Cancer Res 63:2010–2015
    PubMed CAS Google Scholar
  49. Le Mee G, Ezzeddine N, Capri M, Ait-Ahmed O (2008) Repeat length and RNA expression level are not primary determinants in CUG expansion toxicity in Drosophila models. PLoS ONE 3:e1466
    Article PubMed Google Scholar
  50. Galvao R, Mendes-Soares L, Camara J, Jaco I, Carmo-Fonseca M (2001) Triplet repeats, RNA secondary structure and toxic gain-of-function models for pathogenesis. Brain Res Bull 56:191–201
    Article PubMed CAS Google Scholar
  51. Goldberg YP, Kalchman MA, Metzler M, Nasir J, Zeisler J, Graham R, Koide HB, O’Kusky J, Sharp AH, Ross CA, Jirik F, Hayden MR (1996) Absence of disease phenotype and intergenerational stability of the CAG repeat in transgenic mice expressing the human Huntington disease transcript. Hum Mol Genet 5:177–185
    Article PubMed CAS Google Scholar
  52. Peel AL, Rao RV, Cottrell BA, Hayden MR, Ellerby LM, Bredesen DE (2001) Double-stranded RNA-dependent protein kinase, PKR, binds preferentially to Huntington’s disease (HD) transcripts and is activated in HD tissue. Hum Mol Genet 10:1531–1538
    Article PubMed CAS Google Scholar
  53. Klinkerfuss GH (1967) An electron microscopic study of myotonic dystrophy. Arch Neurol 16:181–193
    PubMed CAS Google Scholar
  54. Ludatscher RM, Kerner H, Amikam S, Gellei B (1978) Myotonia dystrophica with heart involvement: an electron microscopic study of skeletal, cardiac, and smooth muscle. J Clin Pathol 31:1057–1064
    Article PubMed CAS Google Scholar
  55. Tian B, White RJ, Xia T, Welle S, Turner DH, Mathews MB, Thornton CA (2000) Expanded CUG repeat RNAs form hairpins that activate the double-stranded RNA-dependent protein kinase PKR. RNA 6:79–87
    Article PubMed CAS Google Scholar
  56. Ebralidze A, Wang Y, Petkova V, Ebralidse K, Junghans RP (2004) RNA leaching of transcription factors disrupts transcription in myotonic dystrophy. Science 303:383–387
    Article PubMed CAS Google Scholar
  57. Osborne RJ, Lin X, Welle S, Sobczak K, O’Rourke JR, Swanson MS, Thornton CA (2009) Transcriptional and post-transcriptional impact of toxic RNA in myotonic dystrophy. Hum Mol Genet 18:1471–1481
    Article PubMed CAS Google Scholar
  58. Milne CA, Hodgkin J (1999) ETR-1, a homologue of a protein linked to myotonic dystrophy, is essential for muscle development in Caenorhabditis elegans. Curr Biol 9:1243–1246
    Article PubMed CAS Google Scholar
  59. Fernandez-Funez P, Nino-Rosales ML, de Gouyon B, She WC, Luchak JM, Martinez P, Turiegano E, Benito J, Capovilla M, Skinner PJ, McCall A, Canal I, Orr HT, Zoghbi HY, Botas J (2000) Identification of genes that modify ataxin-1-induced neurodegeneration. Nature 408:101–106
    Article PubMed CAS Google Scholar
  60. Siomi H, Dreyfuss G (1997) RNA-binding proteins as regulators of gene expression. Curr Opin Genet Dev 7:345–353
    Article PubMed CAS Google Scholar

Download references